3-iodobenzylguanidine has been researched along with crizotinib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
George, RE; Matthay, KK; Yu, AL | 1 |
1 review(s) available for 3-iodobenzylguanidine and crizotinib
Article | Year |
---|---|
Promising therapeutic targets in neuroblastoma.
Topics: 3-Iodobenzylguanidine; Anaplastic Lymphoma Kinase; Antibodies, Monoclonal; Child; Child, Preschool; Combined Modality Therapy; Crizotinib; Gangliosides; Humans; Molecular Targeted Therapy; Neural Crest; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Precision Medicine; Pyrazoles; Pyridines; Radiopharmaceuticals; Receptor Protein-Tyrosine Kinases | 2012 |